ABT-384 is a potent and selective 11beta-HSD1 inhibitor, reducing enzyme activity in the liver and CNS. It modulates the HPA axis, increasing ACTH, cortisol, and sex hormones, supporting its investigation in preclinical models for Alzheimers disease and major depressive disorder research.